期刊文献+

大肠癌联合脏器切除32例体会

Multi-visceral resection in the treatment of colorectal carcinoma:An analysis of 32 cases
下载PDF
导出
摘要 目的探讨联合脏器切除在晚期大肠癌发生肿瘤组织浸润周围脏器或肝脏转移中的运用价值和可行性。方法对我院1998年7月-2005年7月施行联合脏器切除的32例晚期大肠癌病人的术后并发症发生情况和5年生存率进行回顾性分析。结果行联合肝叶切除的9例中有3例生存5年;行联合周围多脏器切除的23例中有11例生存5年。5年生存率分别为33.33%和47.83%。本组病例均无致死性并发症发生。结论联合脏器切除可提高晚期大肠癌病人的生活质量和5年生存率。临床上对此类病人的治疗应持积极的态度。 Objective To evaluate the value and indications of combined viscera resection for ad- vanced colorectal carcinoma involving peripheral tissue or hepatic metastases. Methods Thirty-two cases of colorectal carcinoma invading peripheral viscera or hepatic metastases were treated with en bloc resection combined other organs in nearly years. The morbidity of postoperative complication and the overall 5-years survival rates were retrospectively analyzed. Results Three cases of 9 combined with liver resection survived more than 5 years and 11 cases of 23 combined with multi-visceral resection survived more than 5 years with the 5-year survival rate being 33. 33% and 47. 83% respectively. No fatal complications occurred in all the patients. Conclusion Multi-visceral resection could improve the quality of life and the 5-year survival rate of the patients with advance colorectal carcinoma.
出处 《腹部外科》 2006年第4期237-238,共2页 Journal of Abdominal Surgery
关键词 大肠 综合疗法 Intestine, large Carcinoma Combined modality therapy
  • 相关文献

参考文献4

二级参考文献40

  • 1Fusai G, Davidson BR. Management of colorectal liver metastases.Colorectal Dis, 2003, 5: 2-23.
  • 2Azoulay D, Castaing D, Smail A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg, 2000, 231: 480-486.
  • 3Stewart GD, O'Suilleabhain CB, Madhavan KK, et al. The extent of resection influences outcome following hepatectomy for colorectal liver metastases. Eur J Surg Oncol, 2004, 30: 370-376.
  • 4Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer:analysis of 1001 consecutive cases. Ann Surg, 1999, 230:309-418.
  • 5Nelson RL, Freels S. A systematic review of hepatic artery chemotherapy after hepatic resection of colorectal cancer metastatic to the liver. Dis Colon Rectum, 2004, 47: 739-745.
  • 6Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med, 1999, 341: 2039-2048.
  • 7Jaeck D, Bachellier P, Nakano H, et al. One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg, 2003, 185:221-229.
  • 8Adam R, Avisar E, Ariche A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol, 2001, 8: 347-353.
  • 9Cromheecke M, Jong KP, Hoekstra HJ.Current treatment for colorectal cancer metastatic to the liver. Eur J Surg Oncol,1999, 25:451-463.
  • 10Tellez C, Benson AB, Lyster MT, et al.Phase Ⅱ trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature.Cancer, 1998, 82: 1250-1259.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部